113 related articles for article (PubMed ID: 37180703)
1. Identifying therapeutic biomarkers of zoledronic acid by metabolomics.
Li X; Wang ZY; Ren N; Wei ZY; Hu WW; Gu JM; Zhang ZL; Yu XT; Wang C
Front Pharmacol; 2023; 14():1084453. PubMed ID: 37180703
[TBL] [Abstract][Full Text] [Related]
2. Long-term protective effects of zoledronic acid on cancellous and cortical bone in the ovariectomized rat.
Gasser JA; Ingold P; Venturiere A; Shen V; Green JR
J Bone Miner Res; 2008 Apr; 23(4):544-51. PubMed ID: 18072878
[TBL] [Abstract][Full Text] [Related]
3. Loss of vertebral bone and mechanical strength in estrogen-deficient rats is prevented by long-term administration of zoledronic acid.
Glatt M; Pataki A; Evans GP; Hornby SB; Green JR
Osteoporos Int; 2004 Sep; 15(9):707-15. PubMed ID: 15024556
[TBL] [Abstract][Full Text] [Related]
4. Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats.
Hornby SB; Evans GP; Hornby SL; Pataki A; Glatt M; Green JR
Calcif Tissue Int; 2003 Apr; 72(4):519-27. PubMed ID: 12574877
[TBL] [Abstract][Full Text] [Related]
5. Zoledronic acid enhances bone-implant osseointegration more than alendronate and strontium ranelate in ovariectomized rats.
Chen B; Li Y; Yang X; Xu H; Xie D
Osteoporos Int; 2013 Jul; 24(7):2115-21. PubMed ID: 23389695
[TBL] [Abstract][Full Text] [Related]
6. Additive effects of zoledronic acid and propranolol on bone density and biochemical markers of bone turnover in osteopenic ovariectomized rats.
Khajuria DK; Razdan R; Mahapatra DR
Rev Bras Reumatol; 2015; 55(2):103-12. PubMed ID: 25582996
[TBL] [Abstract][Full Text] [Related]
7. Zoledronic acid in combination with alfacalcidol has additive effects on trabecular microarchitecture and mechanical properties in osteopenic ovariectomized rats.
Khajuria DK; Razdan R; Mahapatra DR
J Orthop Sci; 2014 Jul; 19(4):646-56. PubMed ID: 24668309
[TBL] [Abstract][Full Text] [Related]
8. Influence of early and late zoledronic acid administration on vertebral structure and strength in ovariectomized rats.
Brouwers JE; van Rietbergen B; Bouxsein ML
Calcif Tissue Int; 2008 Sep; 83(3):186-91. PubMed ID: 18712432
[TBL] [Abstract][Full Text] [Related]
9. The effect of bone morphometric changes on orthodontic tooth movement in an osteoporotic animal model.
Hashimoto M; Hotokezaka H; Sirisoontorn I; Nakano T; Arita K; Tanaka M; Yoshida N
Angle Orthod; 2013 Sep; 83(5):766-73. PubMed ID: 23445276
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Denosumab and Zoledronic Acid in Postmenopausal Women With Osteoporosis: Bone Mineral Density (BMD) and Trabecular Bone Score (TBS).
Kang T; Park SY; Lee SH; Park JH; Suh SW
J Korean Med Sci; 2022 Apr; 37(13):e68. PubMed ID: 35380023
[TBL] [Abstract][Full Text] [Related]
11. Does resveratrol favor peri-implant bone repair in rats with ovariectomy-induced osteoporosis? Gene expression, counter-torque and micro-CT analysis.
Zamai RS; Corrêa MG; Ribeiro FV; Cirano FR; Casati MZ; Messora MR; Pimentel SP
Braz Oral Res; 2023; 37():e003. PubMed ID: 36700588
[TBL] [Abstract][Full Text] [Related]
12. Diminished Progression of Periapical Lesions with Zoledronic Acid in Ovariectomized Rats.
Wayama MT; Yoshimura H; Ohba S; Yoshida H; Matsuda S; Kobayashi J; Kobayashi M; Gomes Filho JE; Sano K
J Endod; 2015 Dec; 41(12):2002-7. PubMed ID: 26490005
[TBL] [Abstract][Full Text] [Related]
13. Effect of zoledronic acid on spinal fusion outcomes in an ovariectomized rat model of osteoporosis.
Yasen M; Li X; Jiang L; Yuan W; Che W; Dong J
J Orthop Res; 2015 Sep; 33(9):1297-304. PubMed ID: 26011820
[TBL] [Abstract][Full Text] [Related]
14. Bone degeneration and recovery after early and late bisphosphonate treatment of ovariectomized wistar rats assessed by in vivo micro-computed tomography.
Brouwers JE; Lambers FM; Gasser JA; van Rietbergen B; Huiskes R
Calcif Tissue Int; 2008 Mar; 82(3):202-11. PubMed ID: 18286219
[TBL] [Abstract][Full Text] [Related]
15. Novel therapeutic intervention for osteoporosis prepared with strontium hydroxyapatite and zoledronic acid: In vitro and pharmacodynamic evaluation.
Khajuria DK; Vasireddi R; Trebbin M; Karasik D; Razdan R
Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():698-708. PubMed ID: 27987763
[TBL] [Abstract][Full Text] [Related]
16. Zoledronic acid combined with percutaneous kyphoplasty in the treatment of osteoporotic compression fracture in a single T12 or L1 vertebral body in postmenopausal women.
Zhang J; Zhang T; Xu X; Cai Q; Zhao D
Osteoporos Int; 2019 Jul; 30(7):1475-1480. PubMed ID: 30976888
[TBL] [Abstract][Full Text] [Related]
17. Metabolomics-driven of relationships among kidney, bone marrow and bone of rats with postmenopausal osteoporosis.
Li X; Wang Y; Gao M; Bao B; Cao Y; Cheng F; Zhang L; Li Z; Shan J; Yao W
Bone; 2022 Mar; 156():116306. PubMed ID: 34963648
[TBL] [Abstract][Full Text] [Related]
18. Zoledronic acid has differential antitumor activity in the pre- and postmenopausal bone microenvironment in vivo.
Ottewell PD; Wang N; Brown HK; Reeves KJ; Fowles CA; Croucher PI; Eaton CL; Holen I
Clin Cancer Res; 2014 Jun; 20(11):2922-32. PubMed ID: 24687923
[TBL] [Abstract][Full Text] [Related]
19. Sequential treatment with zoledronic acid followed by teriparatide or vice versa increases bone mineral density and bone strength in ovariectomized rats.
Shimizu T; Tanaka T; Kobayashi T; Kudo I; Nakatsugawa M; Takakura A; Takao-Kawabata R; Ishizuya T
Bone Rep; 2017 Dec; 7():70-82. PubMed ID: 28948197
[TBL] [Abstract][Full Text] [Related]
20. Effect of zoledronate acid treatment on osseointegration and fixation of implants in autologous iliac bone grafts in ovariectomized rabbits.
Qi M; Hu J; Li J; Li J; Dong W; Feng X; Yu J
Bone; 2012 Jan; 50(1):119-27. PubMed ID: 22023930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
